Inventiva (IVA) EBITDA (2019 - 2025)

Inventiva (IVA) posted quarterly EBITDA of $846705.8 for Q2 2025, up 927.63% year-over-year from $82393.7 in Q2 2024, and up 934.06% quarter-over-quarter from -$101516.6 in Q4 2024.

Inventiva (IVA) EBITDA (2019 - 2025) Analysis & Trends

Inventiva's EBITDA history runs 7 years deep, the most recent figure standing at $846705.8 for Q2 2025.

  • In Q2 2025, EBITDA rose 927.63% year-over-year to $846705.8; the TTM figure through Jun 2025 stood at $348077.4 (up 148.03% YoY), while the FY2025 annual figure was -$164.1 million, down 57.45% from the prior year.
  • EBITDA for Q2 2025 stood at $846705.8, up from -$101516.6 in the prior quarter.
  • The five-year high for EBITDA was $846705.8 in Q2 2025, with the low at -$16.5 million in Q2 2021.
  • The 5-year median for EBITDA is -$163828.6 (2022), against an average of -$3.6 million.
  • The sharpest annual moves came in 2021 and 2025: EBITDA sank 68.62% in 2021, then jumped 927.63% in 2025.
  • Inventiva's EBITDA stood at -$16.5 million in 2021, then surged by 98.91% to -$179563.5 in 2022, then slumped by 64.18% to -$294807.5 in 2023, then jumped by 65.57% to -$101516.6 in 2024, then surged by 934.06% to $846705.8 in 2025.
  • Business Quant data shows IVA's EBITDA at $846705.8 in Q2 2025, -$101516.6 in Q4 2024, and -$102304.3 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 493.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -505.13 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 325.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -2.33 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 133.12 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 231.44 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -1.55 Mn
10 Inventiva 888.89 Mn 888.89 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 846,705.85
Dec 31, 2024 -101,516.56
Jun 30, 2024 -102,304.32
Dec 31, 2023 -294,807.54
Jun 30, 2023 -148,093.72
Dec 31, 2022 -179,563.54
Jun 30, 2021 -16.46 Mn
Mar 31, 2021 -11.99 Mn
Dec 31, 2020 -35.43 Mn
Jun 30, 2020 -9.76 Mn
Mar 31, 2020 -7.51 Mn
Dec 31, 2019 -33.55 Mn